Synopsys (SNPS) 10-Q 26 Feb 14 2014 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Jan. 31, 2014	Feb. 24, 2014
Document Information [Line Items]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	31-Jan-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q1	'
Trading Symbol	'SNPS	'
Entity Registrant Name	'SYNOPSYS INC	'
Entity Central Index Key	'0000883241	'
Current Fiscal Year End Date	'--10-31	'
Entity Filer Category	'Large Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	154,083,614

Unaudited_Condensed_Consolidat

Unaudited Condensed Consolidated Balance Sheets (USD $)	Jan. 31, 2014	Oct. 31, 2013
In Thousands, unless otherwise specified
ASSETS	'	'
Cash and cash equivalents	$893,053	$1,022,441	[1]
Accounts receivable, net	246,774	256,026	[1]
Deferred income taxes	93,409	92,058	[1]
Income taxes receivable and prepaid taxes	19,142	18,277	[1]
Prepaid and other current assets	68,487	59,175	[1]
Total current assets	1,320,865	1,447,977	[1]
Property and equipment, net	197,335	197,600	[1]
Goodwill	1,966,819	1,975,971	[1]
Intangible assets, net	307,912	335,425	[1]
Long-term prepaid taxes	7,119	7,935	[1]
Long-term deferred income taxes	235,460	243,066	[1]
Other long-term assets	156,646	150,961	[1]
Total assets	4,192,156	4,358,935	[1]
LIABILITIES AND STOCKHOLDERS' EQUITY	'	'
Accounts payable and accrued liabilities	217,404	358,197	[1]
Accrued income taxes	11,217	7,168	[1]
Deferred revenue	778,082	827,554	[1]
Short-term debt	30,000	30,000	[1]
Total current liabilities	1,036,703	1,222,919	[1]
Long-term accrued income taxes	50,630	53,064	[1]
Long-term deferred revenue	54,743	54,736	[1]
Long-term debt	67,500	75,000	[1]
Other long-term liabilities	159,365	164,939	[1]
Total liabilities	1,368,941	1,570,658	[1]
Stockholders' equity:	'	'
Preferred Stock, $0.01 par value: 2,000 shares authorized; none outstanding	'	'	[1]
Common Stock, $0.01 par value: 400,000 shares authorized; 154,053 and 154,169 shares outstanding, respectively	1,541	1,542	[1]
Capital in excess of par value	1,601,935	1,597,244	[1]
Retained earnings	1,382,199	1,324,854	[1]
Treasury stock, at cost: 3,211 and 3,095 shares, respectively	-116,035	-106,668	[1]
Accumulated other comprehensive income (loss)	-46,425	-28,695	[1]
Total stockholders' equity	2,823,215	2,788,277	[1]
Total liabilities and stockholders' equity	$4,192,156	$4,358,935	[1]
[1]	Derived from audited financial statements.

Unaudited_Condensed_Consolidat1

Unaudited Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Jan. 31, 2014	Oct. 31, 2013
In Thousands, except Per Share data, unless otherwise specified
Preferred Stock, par value	$0.01	$0.01	[1]
Preferred Stock, shares authorized	2,000	2,000	[1]
Preferred Stock, shares outstanding	'	'	[1]
Common Stock, par value	$0.01	$0.01	[1]
Common Stock, shares authorized	400,000	400,000	[1]
Common Stock, shares outstanding	154,053	154,169	[1]
Treasury stock, shares	3,211	3,095	[1]
[1]	Derived from audited financial statements.

Unaudited_Condensed_Consolidat2

Unaudited Condensed Consolidated Statements Of Operations (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013
Revenue:	'	'
Time-based license	$400,146	$385,959
Upfront license	33,972	30,789
Maintenance and service	44,833	58,389
Total revenue	478,951	475,137
Cost of revenue:	'	'
License	62,825	64,492
Maintenance and service	20,271	20,055
Amortization of intangible assets	22,753	26,516
Total cost of revenue	105,849	111,063
Gross margin	373,102	364,074
Operating expenses:	'	'
Research and development	167,543	157,510
Sales and marketing	105,792	101,758
General and administrative	34,233	37,938
Amortization of intangible assets	5,378	5,887
Total operating expenses	312,946	303,093
Operating income	60,156	60,981
Other income (expense), net	11,028	10,749
Income before provision for income taxes	71,184	71,730
Provision (benefit) for income taxes	3,488	1,808
Net income	$67,696	$69,922
Net income per share:	'	'
Basic	$0.44	$0.46
Diluted	$0.43	$0.45
Shares used in computing per share amounts:	'	'
Basic	154,066	151,477
Diluted	156,756	154,531

Unaudited_Condensed_Consolidat3

Unaudited Condensed Consolidated Statements Of Comprehensive Income (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013
Net income	$67,696	$69,922
Other comprehensive income (loss):	'	'
Change in foreign currency translation adjustment	-13,849	-6,842
Cash flow hedges:	'	'
Deferred gain (loss), net of tax of $1,329 and $344, respectively	-575	5,825
Reclassification adjustment (gain) loss included in net income, net of tax of $294 and $(56), respectively	-3,306	279
Other comprehensive income (loss), net of tax effects	-17,730	-738
Comprehensive income	$49,966	$69,184

Unaudited_Condensed_Consolidat4

Unaudited Condensed Consolidated Statements Of Comprehensive Income (Parenthetical) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013
Deferred gain (loss), tax	$1,329	$344
Reclassification adjustment (gain) loss included in net income, tax	$294	($56)

Unaudited_Condensed_Consolidat5

Unaudited Condensed Consolidated Statements Of Cash Flows (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014		Jan. 31, 2013
Cash flow from operating activities:	'		'
Net income	$67,696		$69,922
Adjustments to reconcile net income to net cash used in operating activities:	'		'
Amortization and depreciation	43,714		47,064
Stock compensation	18,118		17,700
Allowance for doubtful accounts	-400		2,083
Deferred income taxes	5,891		-4,900
Loss (gain) on sales of investments	-6,529		'
Net changes in operating assets and liabilities, net of acquired assets and liabilities:	'		'
Accounts receivable	7,910		20,341
Prepaid and other current assets	-13,635		-23,329
Other long-term assets	-6,695		-10,484
Accounts payable and other liabilities	-134,902		-152,207
Income taxes	-10,068		-1,597
Deferred revenue	-44,992		-56,031
Net cash used in operating activities	-73,892		-91,438
Cash flows from investing activities:	'		'
Purchases of property and equipment	-14,353		-13,980
Cash paid for intangible assets	-900		'
Sales of long-term investments	6,791		'
Capitalization of software development costs	-902		-825
Net cash used in investing activities	-9,364		-14,805
Cash flows from financing activities:	'		'
Principal payments on capital leases	-111		-409
Acquisition of non-controlling interests	'		-44,004
Repayment of debt	-7,748		-7,619
Issuances of common stock	21,581		15,615
Purchases of treasury stock	-54,747		'
Net cash (used in) provided by financing activities	-41,025		-36,417
Effect of exchange rate changes on cash and cash equivalents	-5,107		-7,357
Net change in cash and cash equivalents	-129,388		-150,017
Cash and cash equivalents, beginning of year	1,022,441	[1]	700,382
Cash and cash equivalents, end of period	$893,053		$550,365
[1]	Derived from audited financial statements.

Description_of_Business

Description of Business	3 Months Ended
	Jan. 31, 2014
Description of Business	'
	Note 1. Description of Business
	Synopsys, Inc. (Synopsys or the Company) is a world leader in supplying the electronic design automation (EDA) software that engineers use to design, create prototypes for and test integrated circuits, also known as chips. The Company also provides software and hardware used to develop the systems that incorporate integrated circuits and the software that runs on those integrated circuits. The Company’s intellectual property (IP) products are pre-designed circuits that engineers use as components of larger chip designs rather than designing those circuits themselves. To complement these product offerings, the Company provides technical services to support these solutions and help its customers develop chips and electronic systems.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended
	Jan. 31, 2014
Summary of Significant Accounting Policies	'
	Note 2. Summary of Significant Accounting Policies
	The Company has prepared the accompanying unaudited condensed consolidated financial statements pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Pursuant to these rules and regulations, the Company has condensed or omitted certain information and footnote disclosures it normally includes in its annual consolidated financial statements prepared in accordance with U.S. generally accepted accounting principles (GAAP). In management’s opinion, the Company has made all adjustments (consisting only of normal, recurring adjustments, except as otherwise indicated) necessary to fairly present its unaudited condensed consolidated balance sheets, results of operations, comprehensive income and cash flows. The Company’s interim period operating results do not necessarily indicate the results that may be expected for any other interim period or for the full fiscal year. These financial statements and accompanying notes should be read in conjunction with the consolidated financial statements and notes thereto in Synopsys’ Annual Report on Form 10-K for the fiscal year ended October 31, 2013 as filed with the SEC on December 20, 2013.
	To prepare financial statements in conformity with GAAP, management must make estimates and assumptions that affect the amounts reported in the unaudited condensed consolidated financial statements and accompanying notes. Actual results could differ from these estimates and may result in material effects on the Company’s operating results and financial position.
	Principles of Consolidation. The unaudited condensed consolidated financial statements include the accounts of the Company and all of its subsidiaries. All significant intercompany accounts and transactions have been eliminated.
	Fiscal Year End. The Company’s fiscal year generally ends on the Saturday nearest to October 31 and consists of 52 weeks, with the exception that approximately every five years, the Company has a 53-week year. When a 53-week year occurs, the Company includes the additional week in the first quarter to realign fiscal quarters with calendar quarters. Fiscal 2014 and 2013 are both 52-week years. The first fiscal quarters of fiscal 2014 and 2013 ended on February 1, 2014 and February 2, 2013, respectively. For presentation purposes, the unaudited condensed consolidated financial statements and accompanying notes refer to the closest calendar month end.
	Subsequent Events. The Company has evaluated subsequent events through the date that these unaudited condensed consolidated financial statements were issued.

Financial_Assets_and_Liabiliti

Financial Assets and Liabilities	3 Months Ended
	Jan. 31, 2014
Financial Assets and Liabilities	'
	Note 3. Financial Assets and Liabilities
	Non-marketable equity securities. The Company’s strategic investment portfolio consists of non-marketable equity securities in privately held companies. The securities accounted for under cost method investments are reported at cost net of impairment losses. Securities accounted for under equity method investments are recorded at cost plus the proportional share of the issuers’ income or loss, which is recorded in the Company’s other income (expense), net. The cost basis of securities sold is based on the specific identification method. Refer to Note 4. Fair Value Measures.
	Derivatives. In accordance with ASC 815, Derivatives and Hedging, the Company recognizes derivative instruments as either assets or liabilities in the unaudited condensed consolidated financial statements at fair value and provides qualitative and quantitative disclosures about such derivatives. The Company operates internationally and is exposed to potentially adverse movements in foreign currency exchange rates. The Company enters into hedges in the form of foreign currency forward contracts to reduce its exposure to foreign currency rate changes on non-functional currency denominated forecasted transactions and balance sheet positions including: (1) certain assets and liabilities, (2) shipments forecasted to occur within approximately one month, (3) future billings and revenue on previously shipped orders, and (4) certain future intercompany invoices denominated in foreign currencies.
	The duration of forward contracts ranges from approximately one month to 21 months, the majority of which are short-term. The Company does not use foreign currency forward contracts for speculative or trading purposes. The Company enters into foreign exchange forward contracts with high credit quality financial institutions that are rated ‘A’ or above and to date has not experienced nonperformance by counterparties. Further, the Company anticipates continued performance by all counterparties to such agreements.
	The assets or liabilities associated with the forward contracts are recorded at fair value in other current assets or accrued liabilities in the unaudited condensed consolidated balance sheets. The accounting for gains and losses resulting from changes in fair value depends on the use of the foreign currency forward contract and whether it is designated and qualifies for hedge accounting.
	Cash Flow Hedging Activities
	Certain foreign exchange forward contracts are designated and qualify as cash flow hedges. These contracts have durations of approximately 21 months or less. Certain forward contracts are rolled over periodically to capture the full length of exposure to the Company’s foreign currency risk, which can be up to three years. To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on the hedged transactions. The effective portion of gains or losses resulting from changes in fair value of these hedges is initially reported, net of tax, as a component of other comprehensive income (OCI), in stockholders’ equity and reclassified into revenue or operating expenses, as appropriate, at the time the hedged transactions affect earnings. We expect a majority of the hedge balance in OCI to be reclassified to the statements of operations within the next twelve months.
	Hedging effectiveness is evaluated monthly using spot rates, with any gain or loss caused by hedging ineffectiveness recorded in other income (expense), net. The premium/discount component of the forward contracts is recorded to other income (expense), net, and is not included in evaluating hedging effectiveness.
	Non-designated Hedging Activities
	The Company’s foreign exchange forward contracts that are used to hedge non-functional currency denominated balance sheet assets and liabilities are not designated as hedging instruments. Accordingly, any gains or losses from changes in the fair value of the forward contracts are recorded in other income (expense), net. The gains and losses on these forward contracts generally offset the gains and losses associated with the underlying assets and liabilities, which are also recorded in other income (expense), net. The duration of the forward contracts for hedging the Company’s balance sheet exposure is approximately one month.
	The Company also has certain foreign exchange forward contracts for hedging certain international revenues and expenses that are not designated as hedging instruments. Accordingly, any gains or losses from changes in the fair value of the forward contracts are recorded in other income (expense), net. The gains and losses on these forward contracts generally offset the gains and losses associated with the foreign currency in operating income. The duration of these forward contracts is usually less than one year. The overall goal of the Company’s hedging program is to minimize the impact of currency fluctuations on its net income over its fiscal year.
	The effects of the changes in the fair values of non-designated forward contracts are summarized as follows:
			Three Months ended
			January 31,
			2014				2013
			(in thousands)
	Gain (loss) recorded in other income (expense), net		$	(943	)		$	3,133
	The notional amounts in the table below for derivative instruments provide one measure of the transaction volume outstanding:
			As of January 31,				As of October 31,
			2014				2013
			(in thousands)
	Total gross notional amount		$	667,009			$	746,801
	Net fair value		$	7,250			$	7,199
	The notional amounts for derivative instruments provide one measure of the transaction volume outstanding as of January 31, 2014 and October 31, 2013, respectively, and do not represent the amount of the Company’s exposure to market gain or loss. The Company’s exposure to market gain or loss will vary over time as a function of currency exchange rates. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.
	The following represents the unaudited condensed consolidated balance sheet location and amount of derivative instrument fair values segregated between designated and non-designated hedge instruments:
			Fair Values of				Fair Values of
			derivative instruments				derivative instruments
			designated as  hedging				not designated as
			instruments				hedging instruments
			(in thousands)
	As of January 31, 2014
	Other current assets		$	12,295			$	861
	Accrued liabilities		$	5,873			$	33
	As of October 31, 2013
	Other current assets		$	12,417			$	20
	Accrued liabilities		$	5,103			$	135
	The following table represents the unaudited condensed consolidated statement of operations location and amount of gains and losses on derivative instrument fair values for designated hedge instruments, net of tax:
			Location of gain (loss)		Amount of gain (loss)				Location of	Amount of
			recognized in OCI on		recognized in OCI on				gain (loss)	gain (loss)
			derivatives		derivatives				reclassified from OCI	reclassified from
					(effective portion)					OCI
										(effective portion)
			(in thousands)
	Three months ended January 31, 2014
	Foreign exchange contracts		Revenue		$	3,188			Revenue	$	2,756
	Foreign exchange contracts		Operating expenses			(3,782	)		Operating expenses		550
	Total				$	(594	)			$	3,306
	Three months ended January 31, 2013
	Foreign exchange contracts		Revenue		$	2,628			Revenue	$	487
	Foreign exchange contracts		Operating expenses			3,323			Operating expenses		(766	)
	Total				$	5,951				$	(279	)
	The following table represents the ineffective portions and portions excluded from effectiveness testing of the hedge gains (losses) for derivative instruments designated as hedging instruments, which are recorded in other income (expense), net:
			Amount of				Amount of gain (loss)
			gain (loss) recognized				recognized in income
			in income statement				statement on
			on derivatives				derivatives
			(ineffective				(excluded from
			portion)(1)				effectiveness testing)(2)
			(in thousands)
	For the three months ended January 31, 2014
	Foreign exchange contracts		$	119			$	1,594
	For the three months ended January 31, 2013
	Foreign exchange contracts		$	367			$	471
-1	The ineffective portion includes forecast inaccuracies.
-2	The portion excluded from effectiveness testing includes the discount earned or premium paid for the contracts.

Fair_Value_Measures

Fair Value Measures	3 Months Ended
	Jan. 31, 2014
Fair Value Measures	'
	Note 4. Fair Value Measures
	ASC 820-10, Fair Value Measurements and Disclosures, defines fair value, establishes guidelines and enhances disclosure requirements for fair value measurements.
	The accounting guidance requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The accounting guidance also establishes a fair value hierarchy based on the independence of the source and objective evidence of the inputs used. There are three fair value hierarchies based upon the level of inputs that are significant to fair value measurement:
	Level 1—Observable inputs that reflect quoted prices (unadjusted) for identical instruments in active markets;
	Level 2—Observable inputs other than quoted prices included in Level 1 for similar instruments in active markets, quoted prices for identical or similar instruments in markets that are not active, and model-driven valuations in which all significant inputs and significant value drivers are observable in active markets; and
	Level 3—Unobservable inputs to the valuation derived from fair valuation techniques in which one or more significant inputs or significant value drivers are unobservable.
	On a recurring basis, the Company measures the fair value of certain of its assets and liabilities, which include cash equivalents, non-qualified deferred compensation plan assets, foreign currency derivative contracts and contingent consideration associated with business combinations.
	The Company’s cash equivalents are classified within Level 1 or Level 2 because they are valued using quoted market prices in an active market or alternative independent pricing sources and models utilizing market observable inputs.
	The Company’s non-qualified deferred compensation plan assets consist of money market and mutual funds invested in domestic and international marketable securities that are directly observable in active markets and are therefore classified within Level 1.
	The Company’s foreign currency derivative contracts are classified within Level 2 because these contracts are not actively traded and the valuation inputs are based on quoted prices and market observable data of similar instruments.
	The Company’s borrowings under its credit and term loan facilities are classified within Level 2 because these borrowings are not actively traded and have a variable interest rate structure based upon market rates currently available to the Company for debt with similar terms and maturities. Refer to Note 7. Credit Facility.
	The Company’s liabilities for contingent consideration are classified within Level 3 because these valuations are based on management assumptions including discount rates and estimated probabilities of achievement of certain milestones which are unobservable in the market. As of January 31, 2014 and October 31, 2013, the fair value of contingent consideration liability was estimated at $0.5 million.
	Assets and Liabilities Measured at Fair Value on a Recurring Basis
	Assets and liabilities measured at fair value on a recurring basis are summarized below as of January 31, 2014:
				Fair Value Measurement Using
	Description	Total		Quoted Prices in Active		Significant Other		Significant
				Markets for Identical Assets		Observable Inputs		Unobservable Inputs
				(Level  1)		(Level 2)		(Level 3)
		(in thousands)
	Assets
	Cash equivalents:
	Money market funds	$	520,271	$	520,271	$	—	$	—
	Prepaid and other current assets:
	Foreign currency derivative contracts		13,156		—		13,156		—
	Other long-term assets:
	Deferred compensation plan assets		133,890		133,890		—		—
	Total assets	$	667,317	$	654,161	$	13,156	$	—
	Liabilities
	Accounts payable and accrued liabilities:
	Foreign currency derivative contracts	$	5,906	$	—	$	5,906	$	—
	Contingent consideration		500		—		—		500
	Total liabilities	$	6,406	$	—	$	5,906	$	500
	Assets and liabilities measured at fair value on a recurring basis are summarized below as of October 31, 2013:
				Fair Value Measurement Using
	Description	Total		Quoted Prices in Active		Significant Other		Significant
				Markets for Identical Assets		Observable Inputs		Unobservable Inputs
				(Level  1)		(Level 2)		(Level 3)
		(in thousands)
	Assets
	Cash equivalents:
	Money market funds	$	552,470	$	552,470	$	—	$	—
	Prepaid and other current assets:
	Foreign currency derivative contracts		12,437		—		12,437		—
	Other long-term assets:
	Deferred compensation plan assets		126,621		126,621		—		—
	Total assets	$	691,528	$	679,091	$	12,437	$	—
	Liabilities
	Accounts payable and accrued liabilities:
	Foreign currency derivative contracts	$	5,238	$	—	$	5,238	$	—
	Contingent consideration		493		—		—		493
	Total liabilities	$	5,731	$	—	$	5,238	$	493
	Assets/Liabilities Measured at Fair Value on a Non-Recurring Basis
	Non-Marketable Equity Securities
	Equity investments in privately-held companies, also called non-marketable equity securities are accounted for using either the cost or equity method of accounting.
	These equity investments are classified within Level 3 as they are valued using significant unobservable inputs or data in an inactive market, and the valuation requires management judgment due to the absence of market price and inherent lack of liquidity. The non-marketable equity securities are measured and recorded at fair value when an event or circumstance which impacts the fair value of these securities indicates an other-than-temporary decline in value has occurred. The Company monitors these investments and generally uses the income approach to assess impairments based primarily on the financial conditions of these companies.
	The Company did not recognize any impairment during the three months ended January 31, 2014 and January 31, 2013.
	As of January 31, 2014, the fair value of the Company’s non-marketable securities was $11.0 million, of which $6.7 million and $4.3 million were accounted for under the cost method and equity method, respectively. As of October 31, 2013 the fair value of non-marketable securities was $11.5 million, of which $6.9 million and $4.6 million were accounted for under the cost method and equity method, respectively. During the three months ended January 31, 2014, the company received a cash distribution of $6.6 million from the liquidation of one of its investments with a cost basis of $0.2 million resulting in a $6.4 million gain, which was recorded to other income (expense), net.

Goodwill_and_Intangible_Assets

Goodwill and Intangible Assets	3 Months Ended
	Jan. 31, 2014
Goodwill and Intangible Assets	'
	Note 5. Goodwill and Intangible Assets
	Goodwill as of January 31, 2014 consisted of the following:
			(in thousands)
	Balance at October 31, 2013		$	1,975,971
	Effect of foreign currency translation			(9,152	)
	Balance at January 31, 2014		$	1,966,819
	Intangible assets as of January 31, 2014 consisted of the following:
			Gross			Accumulated		Net Assets
			Assets			Amortization
			(in thousands)
	Core/developed technology		$	382,311		$	243,652	$	138,659
	Customer relationships			176,970			74,762		102,208
	Contract rights intangible			140,015			85,851		54,164
	Covenants not to compete			2,530			2,497		33
	Trademarks and trade names			10,879			5,770		5,109
	In-process research and development (IPR&D)(1)			3,688			—		3,688
	Capitalized software development costs			19,092			15,041		4,051
	Total		$	735,485		$	427,573	$	307,912
	-1	IPR&D is reclassified to core/developed technology upon completion or is written off upon abandonment.
	Intangible assets as of October 31, 2013 consisted of the following:
			Gross			Accumulated		Net Assets
			Assets			Amortization
			(in thousands)
	Core/developed technology		$	380,724		$	228,065	$	152,659
	Customer relationships			177,151			69,745		107,406
	Contract rights intangible			140,517			78,950		61,567
	Covenants not to compete			2,530			2,480		50
	Trademarks and trade names			10,891			5,459		5,432
	In-process research and development (IPR&D)(1)			4,298			—		4,298
	Capitalized software development costs			18,190			14,177		4,013
	Total		$	734,301		$	398,876	$	335,425
	-1	IPR&D is reclassified to core/developed technology upon completion or is written off upon abandonment.
	Amortization expense related to intangible assets consisted of the following:
			Three Months Ended
			January 31,
			2014			2013
			(in thousands)
	Core/developed technology		$	15,621		$	17,134
	Customer relationships			5,053			5,373
	Contract rights intangible			7,126			9,377
	Covenants not to compete			17			33
	Trademarks and trade names			314			486
	Capitalized software development costs(1)			864			786
	Total		$	28,995		$	33,189
	-1	Amortization of capitalized software development costs is included in cost of license revenue in the unaudited condensed consolidated statements of operations.
	The following table presents the estimated future amortization of intangible assets:
	Fiscal Year		(in thousands)
	Remainder of fiscal 2014		$	82,555
	2015			94,039
	2016			59,147
	2017			26,354
	2018			14,628
	2019 and thereafter			27,501
	IPR&D(1)			3,688
	Total		$	307,912
	-1	IPR&D projects are estimated to be completed within one year as of January 31, 2014. Assets are amortized over their useful life upon completion of the project or are written off upon abandonment.

Liabilities

Liabilities	3 Months Ended
	Jan. 31, 2014
Liabilities	'
	Note 6. Liabilities
	Accounts payable and accrued liabilities consist of:
		January 31,		October 31,
		2014		2013
		(in thousands)
	Payroll and related benefits	$	166,099	$	302,374
	Other accrued liabilities		43,221		47,248
	Accounts payable		8,084		8,575
	Total	$	217,404	$	358,197
	Other long-term liabilities consist of:
		January 31,		October 31,
		2014		2013
		(in thousands)
	Deferred compensation liability	$	133,890	$	126,621
	Other long-term liabilities		25,475		38,318
	Total	$	159,365	$	164,939

Credit_Facility

Credit Facility	3 Months Ended
	Jan. 31, 2014
Credit Facility	'
	Note 7. Credit Facility
	On February 17, 2012, the Company entered into an agreement with several lenders (the Credit Agreement) providing for (i) a $350.0 million senior unsecured revolving credit facility (the Revolver) and (ii) a $150.0 million senior unsecured term loan facility (the Term Loan). Principal payments on a portion of the Term Loan are due in equal quarterly installments of $7.5 million, with the remainder due when the Credit Agreement expires in October 2016. The Company can elect to make prepayments on the Term Loan, in whole or in part, without premium or penalty. Subject to obtaining additional commitments from lenders, the principal amount of the loans provided under the Credit Agreement may be increased by the Company by up to an additional $150.0 million through October 13, 2015. The Credit Agreement contains financial covenants requiring the Company to operate within a maximum leverage ratio and maintain specified levels of cash, as well as other non-financial covenants.
	As of January 31, 2014, the Company had a $97.5 million outstanding balance under the Term Loan, of which $67.5 million is classified as long-term, and no outstanding balance under the Revolver. As of October 31, 2013, the Company had a $105.0 million outstanding balance under the Term Loan, of which $75.0 million is classified as long-term, and no outstanding balance under the Revolver. Borrowings bear interest at a floating rate based on a margin over the Company’s choice of market observable base rates as defined in the Credit Agreement. At January 31, 2014, borrowings under the Term Loan bore interest at LIBOR + 1.125% and the applicable interest rate for the Revolver was LIBOR + 0.975%. In addition, commitment fees are payable on the Revolver at rates between 0.150% and 0.300% per year based on the Company’s leverage ratio on the daily amount of the revolving commitment.
	These borrowings under the Credit Agreement have a variable interest rate structure and are classified within Level 2 of the fair value hierarchy. The carrying amount of the short-term and long-term debt approximates the estimated fair value.

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Income (Loss)	3 Months Ended
	Jan. 31, 2014
Accumulated Other Comprehensive Income (Loss)	'
	Note 8. Accumulated Other Comprehensive Income (Loss)
	Components of accumulated other comprehensive income (loss), on an after-tax basis where applicable, were as follows:
		January 31,			October 31,
		2014			2013
		(in thousands)
	Cumulative currency translation adjustments	$	(40,696	)	$	(26,848	)
	Unrealized gain (loss) on derivative instruments, net of taxes		(5,729	)		(1,847	)
	Total accumulated other comprehensive income (loss)	$	(46,425	)	$	(28,695	)
	The effect of amounts reclassified out of each component of accumulated other comprehensive income (loss) into net income was as follows:
		Three Months Ended
		January 31,
		2014			2013
		(in thousands)
	Reclassifications from accumulated other comprehensive income (loss) into unaudited condensed consolidated statement of operations:
	Gain (loss) on cash flow hedges, net of taxes
	Revenues	$	2,756		$	487
	Operating expenses		550			(766	)
	Total reclassifications into net income	$	3,306		$	(279	)

Stock_Repurchase_Program

Stock Repurchase Program	3 Months Ended
	Jan. 31, 2014
Stock Repurchase Program	'
	Note 9. Stock Repurchase Program
	The Company’s Board of Directors (Board) previously approved a stock repurchase program pursuant to which the Company was authorized to purchase up to $500.0 million of its common stock and has periodically replenished the stock repurchase program to such amount. The Board replenished the stock repurchase program up to $500.0 million on December 3, 2013, as announced on December 4, 2013. The program does not obligate Synopsys to acquire any particular amount of common stock, and the program may be suspended or terminated at any time by Synopsys’ Chief Financial Officer or the Board. The Company repurchases shares to offset dilution caused by ongoing stock issuances from existing equity plans for equity compensation awards and issuances related to acquisitions, and when management believes it is a good use of cash. Repurchases are transacted in accordance with Rule 10b-18 of the Securities Exchange Act of 1934 (Exchange Act) and may be made through any means including, but not limited to, open market purchases, plans executed under Rule 10b5-1(c) of the Exchange Act and structured transactions. As of January 31, 2014, $445.3 million remained available for further repurchases under the program.
	The Company reissued 1.3 million and 1.1 million shares of treasury stock during the three months ended January 31, 2014 and January 31, 2013, respectively.

Stock_Compensation

Stock Compensation	3 Months Ended
	Jan. 31, 2014
Stock Compensation	'
	Note 10. Stock Compensation
	The compensation cost recognized in the unaudited condensed consolidated statements of operations for the Company’s stock compensation arrangements was as follows:
		Three Months Ended
		January 31,
		2014			2013
		(in thousands)
	Cost of license	$	1,861		$	1,817
	Cost of maintenance and service		428			479
	Research and development expense		8,916			8,136
	Sales and marketing expense		3,732			3,673
	General and administrative expense		3,181			3,595
	Stock compensation expense before taxes		18,118			17,700
	Income tax benefit		(4,220	)		(3,959	)
	Stock compensation expense after taxes	$	13,898		$	13,741
	As of January 31, 2014, there was $119.4 million of unamortized share-based compensation expense, which is expected to be amortized over a weighted-average period of approximately 2.5 years.
	The intrinsic values of equity awards exercised during the periods are as follows:
		Three Months Ended
		January 31,
		2014			2013
		(in thousands)
	Intrinsic value of awards exercised	$	16,199		$	7,705

Net_Income_per_Share

Net Income per Share	3 Months Ended
	Jan. 31, 2014
Net Income per Share	'
	Note 11. Net Income per Share
	The Company computes basic net income per share by dividing net income available to common stockholders by the weighted-average number of common shares outstanding during the period. Diluted net income per share reflects the dilution from potential common shares outstanding, such as stock options and unvested restricted stock units and awards, during the period using the treasury stock method.
	The table below reconciles the weighted-average common shares used to calculate basic net income per share with the weighted-average common shares used to calculate diluted net income per share:
			Three Months Ended
			January 31,
			2014		2013
			(in thousands, except
			per share amounts)
	Numerator:
	Net income		$	67,696	$	69,922
	Denominator:
	Weighted-average common shares for basic net income per share			154,066		151,477
	Dilutive effect of potential common shares from equity-based compensation			2,690		3,054
	Weighted-average common shares for diluted net income per share			156,756		154,531
	Net income per share:
	Basic		$	0.44	$	0.46
	Diluted		$	0.43	$	0.45
	Anti-dilutive employee stock-based awards excluded(1)			1,378		2,573
	-1	These stock options and unvested restricted stock units and restricted stock awards were anti-dilutive for the respective periods and are excluded in calculating diluted net income per share. While such awards were antidilutive for the respective periods, they could be dilutive in the future.

Segment_Disclosure

Segment Disclosure	3 Months Ended
	Jan. 31, 2014
Segment Disclosure	'
	Note 12. Segment Disclosure
	ASC 280, Segment Reporting, requires disclosures of certain information regarding operating segments, products and services, geographic areas of operation and major customers. Segment reporting is based upon the “management approach,” i.e., how management organizes the Company’s operating segments for which separate financial information is (1) available and (2) evaluated regularly by the Chief Operating Decision Makers (CODMs) in deciding how to allocate resources and in assessing performance. Synopsys’ CODMs are the Company’s two Co-Chief Executive Officers.
	The Company operates in a single segment to provide software products and consulting services in the EDA software industry. In making operating decisions, the CODMs primarily consider consolidated financial information, accompanied by disaggregated information about revenues by geographic region. Specifically, the CODMs consider where individual “seats” or licenses to the Company’s products are located in allocating revenue to particular geographic areas. Revenue is defined as revenues from external customers. Goodwill is not allocated since the Company operates in one reportable operating segment. Revenues related to operations in the United States and other geographic areas were:
		Three Months Ended
		January 31,
		2014		2013
		(in thousands)
	Revenue:
	United States	$	233,627	$	233,133
	Europe		66,654		63,439
	Japan		64,320		69,648
	Asia Pacific and Other		114,350		108,917
	Consolidated	$	478,951	$	475,137
	Geographic revenue data for multi-region, multi-product transactions reflect internal allocations and are therefore subject to certain assumptions and the Company’s methodology.
	One customer accounted for 11.6% and 11.0% of the Company’s unaudited condensed consolidated revenue in the three months ended January 31, 2014 and 2013, respectively.

Other_Income_Expense_net

Other Income (Expense), net	3 Months Ended
	Jan. 31, 2014
Other Income (Expense), net	'
	Note 13. Other Income (Expense), net
	The following table presents the components of other income (expense), net:
			Three Months Ended
			January 31,
			2014			2013
			(in thousands)
	Interest income		$	367		$	335
	Interest expense			(357	)		(464	)
	Gain (loss) on assets related to executive deferred compensation plan			1,042			5,413
	Foreign currency exchange gain (loss)			893			4,404
	Other, net(1)			9,083			1,061
	Total		$	11,028		$	10,749
	-1	Refer to Note 4. Fair Value Measures.

Taxes

Taxes	3 Months Ended
	Jan. 31, 2014
Taxes	'
	Note 14. Taxes
	Effective Tax Rate
	The Company estimates its annual effective tax rate at the end of each fiscal quarter. The Company’s estimate takes into account estimations of annual pre-tax income, the geographic mix of pre-tax income and the Company’s interpretations of tax laws and possible outcomes of audits.
	The following table presents the provision for income taxes and the effective tax rates:
		Three Months Ended
		January 31,
		2014			2013
		(in thousands)
	Income before income taxes	$	71,184		$	71,730
	Provision for income tax	$	3,488		$	1,808
	Effective tax rate		4.9	%		2.5	%
	The Company’s effective tax rate for the three months ended January 31, 2014 is lower than the statutory federal income tax rate of 35% primarily due to the lower tax rates applicable to its non-U.S. operations, U.S. federal and California research tax credits, and a settlement with the Internal Revenue Service (IRS) for fiscal 2012, partially offset by state taxes and non-deductible stock compensation.
	The Company’s effective tax rate for the three months ended January 31, 2014 as compared to the three months ended January 31, 2013 was higher principally due to the reinstatement of the U.S. federal research tax credit in the first quarter of fiscal 2013 as well as the reversal of deferred taxes resulting from the merger of a foreign affiliate partially offset by tax benefits of settlement with the IRS in the first quarter of fiscal 2014 of the Company’s fiscal 2012 tax filing. The expiration of the U.S. federal research tax credit on December 31, 2013 resulted in only two months of tax credit in fiscal 2014, compared to fiscal 2013 that had an additional tax credit for ten months of fiscal 2012 due to the reinstatement of the tax credit as well as a full year tax credit for fiscal 2013.
	The Company’s total gross unrecognized tax benefits at January 31, 2014 are $115.0 million exclusive of interest and penalties. If the total gross unrecognized tax benefits at January 31, 2014 were recognized in the future, approximately $115.0 million would decrease the effective tax rate.
	The timing of the resolution of income tax examinations is highly uncertain as well as the amounts and timing of various tax payments that are part of the settlement process. This could cause large fluctuations in the balance sheet classification of current and non-current assets and liabilities. The Company believes that in the coming 12 months, it is reasonably possible that either certain audits will conclude or the statute of limitations on certain state and foreign income and withholding taxes will expire, or both. Given the uncertainty as to ultimate settlement terms, the timing of payment and the impact of such settlements on other uncertain tax positions, the range of the estimated potential decrease in underlying unrecognized tax benefits is between $0 and $36 million.
	IRS Examinations
	On November 6, 2013, the Company reached final settlement with the IRS on the remaining fiscal 2012 issues and recognized approximately $10 million in unrecognized tax benefits in the first quarter of fiscal 2014.

Subsequent_Events

Subsequent Events	3 Months Ended
	Jan. 31, 2014
Subsequent Events	'
	Note 15. Subsequent Events
	On February 19, 2014, the Company entered into a definitive agreement to acquire Coverity, Inc. (Coverity), a leading provider of software quality, testing, and security tools, for a total consideration of approximately $375 million in cash and assumption of outstanding unvested Coverity stock options. The acquisition is anticipated to close in the second fiscal quarter of 2014. The Company expects to fund the acquisition using a combination of cash and debt.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Jan. 31, 2014
Principles of Consolidation	'
	Principles of Consolidation. The unaudited condensed consolidated financial statements include the accounts of the Company and all of its subsidiaries. All significant intercompany accounts and transactions have been eliminated.
Fiscal Year End	'
	Fiscal Year End. The Company’s fiscal year generally ends on the Saturday nearest to October 31 and consists of 52 weeks, with the exception that approximately every five years, the Company has a 53-week year. When a 53-week year occurs, the Company includes the additional week in the first quarter to realign fiscal quarters with calendar quarters. Fiscal 2014 and 2013 are both 52-week years. The first fiscal quarters of fiscal 2014 and 2013 ended on February 1, 2014 and February 2, 2013, respectively. For presentation purposes, the unaudited condensed consolidated financial statements and accompanying notes refer to the closest calendar month end.
Subsequent Events	'
	Subsequent Events. The Company has evaluated subsequent events through the date that these unaudited condensed consolidated financial statements were issued.

Financial_Assets_and_Liabiliti1

Financial Assets and Liabilities (Tables)	3 Months Ended
	Jan. 31, 2014
Effects on Changes in Fair Values of Non-Designated Forward Contracts	'
	The effects of the changes in the fair values of non-designated forward contracts are summarized as follows:
			Three Months ended
			January 31,
			2014				2013
			(in thousands)
	Gain (loss) recorded in other income (expense), net		$	(943	)		$	3,133
Notional Amounts of Derivative Instruments	'
	The notional amounts in the table below for derivative instruments provide one measure of the transaction volume outstanding:
			As of January 31,				As of October 31,
			2014				2013
			(in thousands)
	Total gross notional amount		$	667,009			$	746,801
	Net fair value		$	7,250			$	7,199
Fair Values of Derivative Instrument Designated and Non-Designated as Hedging Instruments in Balance Sheet	'
	The following represents the unaudited condensed consolidated balance sheet location and amount of derivative instrument fair values segregated between designated and non-designated hedge instruments:
			Fair Values of				Fair Values of
			derivative instruments				derivative instruments
			designated as  hedging				not designated as
			instruments				hedging instruments
			(in thousands)
	As of January 31, 2014
	Other current assets		$	12,295			$	861
	Accrued liabilities		$	5,873			$	33
	As of October 31, 2013
	Other current assets		$	12,417			$	20
	Accrued liabilities		$	5,103			$	135
Income Statement Location and Amount of Gains and Losses on Derivative Instrument Fair Values for Designated Hedge Instruments, Net of Tax	'
	The following table represents the unaudited condensed consolidated statement of operations location and amount of gains and losses on derivative instrument fair values for designated hedge instruments, net of tax:
			Location of gain (loss)		Amount of gain (loss)				Location of	Amount of
			recognized in OCI on		recognized in OCI on				gain (loss)	gain (loss)
			derivatives		derivatives				reclassified from OCI	reclassified from
					(effective portion)					OCI
										(effective portion)
			(in thousands)
	Three months ended January 31, 2014
	Foreign exchange contracts		Revenue		$	3,188			Revenue	$	2,756
	Foreign exchange contracts		Operating expenses			(3,782	)		Operating expenses		550
	Total				$	(594	)			$	3,306
	Three months ended January 31, 2013
	Foreign exchange contracts		Revenue		$	2,628			Revenue	$	487
	Foreign exchange contracts		Operating expenses			3,323			Operating expenses		(766	)
	Total				$	5,951				$	(279	)
Ineffective Portion and Portion Excluded from Effectiveness Testing of Derivative Hedge Gains (Losses)	'
	The following table represents the ineffective portions and portions excluded from effectiveness testing of the hedge gains (losses) for derivative instruments designated as hedging instruments, which are recorded in other income (expense), net:
			Amount of				Amount of gain (loss)
			gain (loss) recognized				recognized in income
			in income statement				statement on
			on derivatives				derivatives
			(ineffective				(excluded from
			portion)(1)				effectiveness testing)(2)
			(in thousands)
	For the three months ended January 31, 2014
	Foreign exchange contracts		$	119			$	1,594
	For the three months ended January 31, 2013
	Foreign exchange contracts		$	367			$	471
	-1	The ineffective portion includes forecast inaccuracies.
	-2	The portion excluded from effectiveness testing includes the discount earned or premium paid for the contracts.

Fair_Value_Measures_Tables

Fair Value Measures (Tables)	3 Months Ended
	Jan. 31, 2014
Assets and Liabilities Measured at Fair Value on Recurring Basis	'
	Assets and liabilities measured at fair value on a recurring basis are summarized below as of January 31, 2014:
				Fair Value Measurement Using
	Description	Total		Quoted Prices in Active		Significant Other		Significant
				Markets for Identical Assets		Observable Inputs		Unobservable Inputs
				(Level  1)		(Level 2)		(Level 3)
		(in thousands)
	Assets
	Cash equivalents:
	Money market funds	$	520,271	$	520,271	$	—	$	—
	Prepaid and other current assets:
	Foreign currency derivative contracts		13,156		—		13,156		—
	Other long-term assets:
	Deferred compensation plan assets		133,890		133,890		—		—
	Total assets	$	667,317	$	654,161	$	13,156	$	—
	Liabilities
	Accounts payable and accrued liabilities:
	Foreign currency derivative contracts	$	5,906	$	—	$	5,906	$	—
	Contingent consideration		500		—		—		500
	Total liabilities	$	6,406	$	—	$	5,906	$	500
	Assets and liabilities measured at fair value on a recurring basis are summarized below as of October 31, 2013:
				Fair Value Measurement Using
	Description	Total		Quoted Prices in Active		Significant Other		Significant
				Markets for Identical Assets		Observable Inputs		Unobservable Inputs
				(Level  1)		(Level 2)		(Level 3)
		(in thousands)
	Assets
	Cash equivalents:
	Money market funds	$	552,470	$	552,470	$	—	$	—
	Prepaid and other current assets:
	Foreign currency derivative contracts		12,437		—		12,437		—
	Other long-term assets:
	Deferred compensation plan assets		126,621		126,621		—		—
	Total assets	$	691,528	$	679,091	$	12,437	$	—
	Liabilities
	Accounts payable and accrued liabilities:
	Foreign currency derivative contracts	$	5,238	$	—	$	5,238	$	—
	Contingent consideration		493		—		—		493
	Total liabilities	$	5,731	$	—	$	5,238	$	493

Goodwill_and_Intangible_Assets1

Goodwill and Intangible Assets (Tables)	3 Months Ended
	Jan. 31, 2014
Summary of Goodwill	'
	Goodwill as of January 31, 2014 consisted of the following:
			(in thousands)
	Balance at October 31, 2013		$	1,975,971
	Effect of foreign currency translation			(9,152	)
	Balance at January 31, 2014		$	1,966,819
Summary of Intangible Assets	'
	Intangible assets as of January 31, 2014 consisted of the following:
			Gross			Accumulated		Net Assets
			Assets			Amortization
			(in thousands)
	Core/developed technology		$	382,311		$	243,652	$	138,659
	Customer relationships			176,970			74,762		102,208
	Contract rights intangible			140,015			85,851		54,164
	Covenants not to compete			2,530			2,497		33
	Trademarks and trade names			10,879			5,770		5,109
	In-process research and development (IPR&D)(1)			3,688			—		3,688
	Capitalized software development costs			19,092			15,041		4,051
	Total		$	735,485		$	427,573	$	307,912
	-1	IPR&D is reclassified to core/developed technology upon completion or is written off upon abandonment.
	Intangible assets as of October 31, 2013 consisted of the following:
			Gross			Accumulated		Net Assets
			Assets			Amortization
			(in thousands)
	Core/developed technology		$	380,724		$	228,065	$	152,659
	Customer relationships			177,151			69,745		107,406
	Contract rights intangible			140,517			78,950		61,567
	Covenants not to compete			2,530			2,480		50
	Trademarks and trade names			10,891			5,459		5,432
	In-process research and development (IPR&D)(1)			4,298			—		4,298
	Capitalized software development costs			18,190			14,177		4,013
	Total		$	734,301		$	398,876	$	335,425
	-1	IPR&D is reclassified to core/developed technology upon completion or is written off upon abandonment.
Amortization Expense Related to Intangible Assets	'
	Amortization expense related to intangible assets consisted of the following:
			Three Months Ended
			January 31,
			2014			2013
			(in thousands)
	Core/developed technology		$	15,621		$	17,134
	Customer relationships			5,053			5,373
	Contract rights intangible			7,126			9,377
	Covenants not to compete			17			33
	Trademarks and trade names			314			486
	Capitalized software development costs(1)			864			786
	Total		$	28,995		$	33,189
	-1	Amortization of capitalized software development costs is included in cost of license revenue in the unaudited condensed consolidated statements of operations.
Estimated Future Amortization of Intangible Assets	'
	The following table presents the estimated future amortization of intangible assets:
	Fiscal Year		(in thousands)
	Remainder of fiscal 2014		$	82,555
	2015			94,039
	2016			59,147
	2017			26,354
	2018			14,628
	2019 and thereafter			27,501
	IPR&D(1)			3,688
	Total		$	307,912
	-1	IPR&D projects are estimated to be completed within one year as of January 31, 2014. Assets are amortized over their useful life upon completion of the project or are written off upon abandonment.

Liabilities_Tables

Liabilities (Tables)	3 Months Ended
	Jan. 31, 2014
Accounts Payable and Accrued Liabilities	'
	Accounts payable and accrued liabilities consist of:
		January 31,		October 31,
		2014		2013
		(in thousands)
	Payroll and related benefits	$	166,099	$	302,374
	Other accrued liabilities		43,221		47,248
	Accounts payable		8,084		8,575
	Total	$	217,404	$	358,197
Other Long-Term Liabilities	'
	Other long-term liabilities consist of:
		January 31,		October 31,
		2014		2013
		(in thousands)
	Deferred compensation liability	$	133,890	$	126,621
	Other long-term liabilities		25,475		38,318
	Total	$	159,365	$	164,939

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Jan. 31, 2014
Components of Accumulated Other Comprehensive Income (Loss)	'
	Components of accumulated other comprehensive income (loss), on an after-tax basis where applicable, were as follows:
		January 31,			October 31,
		2014			2013
		(in thousands)
	Cumulative currency translation adjustments	$	(40,696	)	$	(26,848	)
	Unrealized gain (loss) on derivative instruments, net of taxes		(5,729	)		(1,847	)
	Total accumulated other comprehensive income (loss)	$	(46,425	)	$	(28,695	)
Effect of Amounts Reclassified out of Each Component of Accumulated Other Comprehensive Income (Loss) into Net Income	'
	The effect of amounts reclassified out of each component of accumulated other comprehensive income (loss) into net income was as follows:
		Three Months Ended
		January 31,
		2014			2013
		(in thousands)
	Reclassifications from accumulated other comprehensive income (loss) into unaudited condensed consolidated statement of operations:
	Gain (loss) on cash flow hedges, net of taxes
	Revenues	$	2,756		$	487
	Operating expenses		550			(766	)
	Total reclassifications into net income	$	3,306		$	(279	)

Stock_Compensation_Tables

Stock Compensation (Tables)	3 Months Ended
	Jan. 31, 2014
Stock Compensation Arrangements	'
	The compensation cost recognized in the unaudited condensed consolidated statements of operations for the Company’s stock compensation arrangements was as follows:
		Three Months Ended
		January 31,
		2014			2013
		(in thousands)
	Cost of license	$	1,861		$	1,817
	Cost of maintenance and service		428			479
	Research and development expense		8,916			8,136
	Sales and marketing expense		3,732			3,673
	General and administrative expense		3,181			3,595
	Stock compensation expense before taxes		18,118			17,700
	Income tax benefit		(4,220	)		(3,959	)
	Stock compensation expense after taxes	$	13,898		$	13,741
Schedule of Intrinsic Value of Equity Awards Exercised	'
	The intrinsic values of equity awards exercised during the periods are as follows:
		Three Months Ended
		January 31,
		2014			2013
		(in thousands)
	Intrinsic value of awards exercised	$	16,199		$	7,705

Net_Income_per_Share_Tables

Net Income per Share (Tables)	3 Months Ended
	Jan. 31, 2014
Reconciliation of Weighted-Average Common Shares Used to Calculate Net Income Per Share	'
	The table below reconciles the weighted-average common shares used to calculate basic net income per share with the weighted-average common shares used to calculate diluted net income per share:
			Three Months Ended
			January 31,
			2014		2013
			(in thousands, except
			per share amounts)
	Numerator:
	Net income		$	67,696	$	69,922
	Denominator:
	Weighted-average common shares for basic net income per share			154,066		151,477
	Dilutive effect of potential common shares from equity-based compensation			2,690		3,054
	Weighted-average common shares for diluted net income per share			156,756		154,531
	Net income per share:
	Basic		$	0.44	$	0.46
	Diluted		$	0.43	$	0.45
	Anti-dilutive employee stock-based awards excluded(1)			1,378		2,573
	-1	These stock options and unvested restricted stock units and restricted stock awards were anti-dilutive for the respective periods and are excluded in calculating diluted net income per share. While such awards were antidilutive for the respective periods, they could be dilutive in the future.

Segment_Disclosure_Tables

Segment Disclosure (Tables)	3 Months Ended
	Jan. 31, 2014
Revenues Related to Operations by Geographic Areas	'
	Revenues related to operations in the United States and other geographic areas were:
		Three Months Ended
		January 31,
		2014		2013
		(in thousands)
	Revenue:
	United States	$	233,627	$	233,133
	Europe		66,654		63,439
	Japan		64,320		69,648
	Asia Pacific and Other		114,350		108,917
	Consolidated	$	478,951	$	475,137

Other_Income_Expense_net_Table

Other Income (Expense), net (Tables)	3 Months Ended
	Jan. 31, 2014
Components of Other Income (Expense), Net	'
	The following table presents the components of other income (expense), net:
			Three Months Ended
			January 31,
			2014			2013
			(in thousands)
	Interest income		$	367		$	335
	Interest expense			(357	)		(464	)
	Gain (loss) on assets related to executive deferred compensation plan			1,042			5,413
	Foreign currency exchange gain (loss)			893			4,404
	Other, net(1)			9,083			1,061
	Total		$	11,028		$	10,749
	-1	Refer to Note 4. Fair Value Measures.

Taxes_Tables

Taxes (Tables)	3 Months Ended
	Jan. 31, 2014
Provision for Income Taxes and Effective Tax Rates	'
	The following table presents the provision for income taxes and the effective tax rates:
		Three Months Ended
		January 31,
		2014			2013
		(in thousands)
	Income before income taxes	$	71,184		$	71,730
	Provision for income tax	$	3,488		$	1,808
	Effective tax rate		4.9	%		2.5	%

Financial_Assets_and_Liabiliti2

Financial Assets and Liabilities - Additional Information (Detail)	3 Months Ended
	Jan. 31, 2014
Financial Assets and Liabilities [Line Items]	'
Shipments period using hedges (in months)	'One
Minimum forward contracts terms (in months)	'One
Forward contracts terms (in months)	'21 months
Period for hedge balance in OCI to be reclassified to statement of operations (in months)	'12 months
Foreign Exchange Contracts | Maximum	'
Financial Assets and Liabilities [Line Items]	'
Duration of foreign exchange forward contracts	'1 year
Cash Flow Hedging | Maximum	'
Financial Assets and Liabilities [Line Items]	'
Derivative maturity period (in months)	21
Derivative maturity period of rolled over currency contracts (in years)	3
Non-Designated Hedging Instrument	'
Financial Assets and Liabilities [Line Items]	'
Forward contracts terms (in months)	'1 month

Effects_on_Changes_in_Fair_Val

Effects on Changes in Fair Values of Non-Designated Forward Contracts (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013
Financial assets and liabilities [Abstract]	'	'
Gain (loss) recorded in other income (expense), net	($943)	$3,133

Notional_Amounts_of_Derivative

Notional Amounts of Derivative Instruments (Detail) (USD $)	Jan. 31, 2014	Oct. 31, 2013
In Thousands, unless otherwise specified
Financial assets and liabilities [Abstract]	'	'
Total gross notional amount	$667,009	$746,801
Net fair value	$7,250	$7,199

Fair_Values_of_Derivative_Inst

Fair Values of Derivative Instrument Designated and Non-Designated as Hedging Instruments in Unaudited Condensed Consolidated Balance Sheet (Detail) (USD $)	Jan. 31, 2014	Oct. 31, 2013
In Thousands, unless otherwise specified
Designated As Hedging Instrument | Other Current Assets	'	'
Financial Assets and Liabilities [Line Items]	'	'
Fair values of derivative instruments	$12,295	$12,417
Designated As Hedging Instrument | Accrued Liabilities	'	'
Financial Assets and Liabilities [Line Items]	'	'
Fair values of derivative instruments	5,873	5,103
Non-Designated Hedging Instrument | Other Current Assets	'	'
Financial Assets and Liabilities [Line Items]	'	'
Fair values of derivative instruments	861	20
Non-Designated Hedging Instrument | Accrued Liabilities	'	'
Financial Assets and Liabilities [Line Items]	'	'
Fair values of derivative instruments	$33	$135

Unaudited_Condensed_Consolidat6

Unaudited Condensed Consolidated Statement of Operations Location and Amount of Gains and Losses on Derivative Instrument Fair Values for Designated Hedge Instruments, Net of Tax (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013
Financial Assets and Liabilities [Line Items]	'	'
Amount of gain (loss) recognized in OCI on derivatives (effective portion)	($594)	$5,951
Amount of gain (loss) reclassified from OCI (effective portion)	3,306	-279
Foreign Exchange Contracts | Revenue	'	'
Financial Assets and Liabilities [Line Items]	'	'
Amount of gain (loss) recognized in OCI on derivatives (effective portion)	3,188	2,628
Amount of gain (loss) reclassified from OCI (effective portion)	2,756	487
Foreign Exchange Contracts | Operating Expenses	'	'
Financial Assets and Liabilities [Line Items]	'	'
Amount of gain (loss) recognized in OCI on derivatives (effective portion)	-3,782	3,323
Amount of gain (loss) reclassified from OCI (effective portion)	$550	($766)

Ineffective_Portion_and_Portio

Ineffective Portion and Portion Excluded from Effectiveness Testing of Derivative Hedge Gains (Losses) (Detail) (Foreign Exchange Contracts, USD $)	3 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014		Jan. 31, 2013
Foreign Exchange Contracts	'		'
Financial Assets and Liabilities [Line Items]	'		'
Amount of gain (loss) recognized in income statement on derivatives (ineffective portion)	$119	[1]	$367	[1]
Amount of gain (loss) recognized in income statement on derivatives (excluded from effectiveness testing)	$1,594	[2]	$471	[2]
[1]	The ineffective portion includes forecast inaccuracies.
[2]	The portion excluded from effectiveness testing includes the discount earned or premium paid for the contracts.

Fair_Value_Measures_Additional

Fair Value Measures - Additional Information (Detail) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013	Oct. 31, 2013
Fair Value Measures [Line Items]	'	'	'
Contingent consideration	$0.50	'	$0.50
Other-than-temporary impairment	0	0	'
Non-marketable equity securities	11	'	11.5
Proceeds from liquidation of investments	6.6	'	'
Cost basis of investment sold	0.2	'	'
Cost Method Investments	'	'	'
Fair Value Measures [Line Items]	'	'	'
Non-marketable equity securities	6.7	'	6.9
Equity Method Investments	'	'	'
Fair Value Measures [Line Items]	'	'	'
Non-marketable equity securities	4.3	'	4.6
Other Income Expense Net	'	'	'
Fair Value Measures [Line Items]	'	'	'
Gain from liquidation of investment	$6.40	'	'

Assets_and_Liabilities_Measure

Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) (Fair Value, Measurements, Recurring, USD $)	Jan. 31, 2014	Oct. 31, 2013
In Thousands, unless otherwise specified
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Total assets	$667,317	$691,528
Total liabilities	6,406	5,731
Money Market Funds (U.S.)	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Cash equivalents	520,271	552,470
Foreign Currency Derivative Contracts	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Prepaid and other current assets	13,156	12,437
Accounts payable and accrued liabilities	5,906	5,238
Deferred Compensation Plan Assets	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Other long-term assets	133,890	126,621
Contingent Consideration	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Accounts payable and accrued liabilities	500	493
Quoted Prices In Active Markets For Identical Assets (Level 1)	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Total assets	654,161	679,091
Quoted Prices In Active Markets For Identical Assets (Level 1) | Money Market Funds (U.S.)	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Cash equivalents	520,271	552,470
Quoted Prices In Active Markets For Identical Assets (Level 1) | Deferred Compensation Plan Assets	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Other long-term assets	133,890	126,621
Significant Other Observable Inputs (Level 2)	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Total assets	13,156	12,437
Total liabilities	5,906	5,238
Significant Other Observable Inputs (Level 2) | Foreign Currency Derivative Contracts	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Prepaid and other current assets	13,156	12,437
Accounts payable and accrued liabilities	5,906	5,238
Significant Unobservable Inputs (Level 3)	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Total liabilities	500	493
Significant Unobservable Inputs (Level 3) | Contingent Consideration	'	'
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]	'	'
Accounts payable and accrued liabilities	$500	$493

Summary_of_Goodwill_Detail

Summary of Goodwill (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014
Goodwill And Intangible Assets [Abstract]	'
Beginning Balance	$1,975,971	[1]
Effect of foreign currency translation	-9,152
Ending balance	$1,966,819
[1]	Derived from audited financial statements.

Summary_of_Intangible_Assets_D

Summary of Intangible Assets (Detail) (USD $)	Jan. 31, 2014		Oct. 31, 2013
In Thousands, unless otherwise specified
Finite-Lived Intangible Assets [Line Items]	'		'
Gross Assets	$735,485		$734,301
Accumulated Amortization	427,573		398,876
Net Assets	307,912		335,425	[1]
Developed And Core Technology	'		'
Finite-Lived Intangible Assets [Line Items]	'		'
Gross Assets	382,311		380,724
Accumulated Amortization	243,652		228,065
Net Assets	138,659		152,659
Customer Relationships	'		'
Finite-Lived Intangible Assets [Line Items]	'		'
Gross Assets	176,970		177,151
Accumulated Amortization	74,762		69,745
Net Assets	102,208		107,406
Contract Rights Intangible	'		'
Finite-Lived Intangible Assets [Line Items]	'		'
Gross Assets	140,015		140,517
Accumulated Amortization	85,851		78,950
Net Assets	54,164		61,567
Covenants Not To Compete	'		'
Finite-Lived Intangible Assets [Line Items]	'		'
Gross Assets	2,530		2,530
Accumulated Amortization	2,497		2,480
Net Assets	33		50
Trademarks and Trade Names	'		'
Finite-Lived Intangible Assets [Line Items]	'		'
Gross Assets	10,879		10,891
Accumulated Amortization	5,770		5,459
Net Assets	5,109		5,432
In-Process Research And Development (IPR&D)	'		'
Finite-Lived Intangible Assets [Line Items]	'		'
Gross Assets	3,688	[2]	4,298	[2]
Net Assets	3,688	[2]	4,298	[2]
Capitalized Software Development Costs	'		'
Finite-Lived Intangible Assets [Line Items]	'		'
Gross Assets	19,092		18,190
Accumulated Amortization	15,041		14,177
Net Assets	$4,051		$4,013
[1]	Derived from audited financial statements.
[2]	IPR&D is reclassified to core/developed technology upon completion or is written off upon abandonment.

Amortization_Expense_Related_t

Amortization Expense Related to Intangible Assets (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014		Jan. 31, 2013
Finite Lived Intangible Assets Amortization Expense [Line Items]	'		'
Amortization expense of intangible assets	$28,995		$33,189
Developed And Core Technology	'		'
Finite Lived Intangible Assets Amortization Expense [Line Items]	'		'
Amortization expense of intangible assets	15,621		17,134
Customer Relationships	'		'
Finite Lived Intangible Assets Amortization Expense [Line Items]	'		'
Amortization expense of intangible assets	5,053		5,373
Contract Rights Intangible	'		'
Finite Lived Intangible Assets Amortization Expense [Line Items]	'		'
Amortization expense of intangible assets	7,126		9,377
Covenants Not To Compete	'		'
Finite Lived Intangible Assets Amortization Expense [Line Items]	'		'
Amortization expense of intangible assets	17		33
Trademarks and Trade Names	'		'
Finite Lived Intangible Assets Amortization Expense [Line Items]	'		'
Amortization expense of intangible assets	314		486
Capitalized Software Development Costs	'		'
Finite Lived Intangible Assets Amortization Expense [Line Items]	'		'
Amortization expense of intangible assets	$864	[1]	$786	[1]
[1]	Amortization of capitalized software development costs is included in cost of license revenue in the unaudited condensed consolidated statements of operations.

Estimated_Future_Amortization_

Estimated Future Amortization of Intangible Assets (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014
Expected Amortization Expense [Line Items]	'
Remainder of fiscal 2014	$82,555
2015	94,039
2016	59,147
2017	26,354
2018	14,628
2019 and thereafter	27,501
IPR&D	3,688	[1]
Total	$307,912
[1]	IPR&D projects are estimated to be completed within one year as of January 31, 2014. Assets are amortized over their useful life upon completion of the project or are written off upon abandonment.

Estimated_Future_Amortization_1

Estimated Future Amortization of Intangible Assets (Parenthetical) (Detail)	Jan. 31, 2014
	Y
Expected Amortization Expense [Line Items]	'
Projects estimated to be completed	1

Components_of_Accounts_Payable

Components of Accounts Payable and Accrued Liabilities (Detail) (USD $)	Jan. 31, 2014	Oct. 31, 2013
In Thousands, unless otherwise specified
Accounts payable and accrued liabilities Current	'	'
Payroll and related benefits	$166,099	$302,374
Other accrued liabilities	43,221	47,248
Accounts payable	8,084	8,575
Total	$217,404	$358,197	[1]
[1]	Derived from audited financial statements.

Components_of_Other_Long_Term_

Components of Other Long Term Liabilities (Detail) (USD $)	Jan. 31, 2014	Oct. 31, 2013
In Thousands, unless otherwise specified
Liabilities Other than long term debt non current	'	'
Deferred compensation liability	$133,890	$126,621
Other long-term liabilities	25,475	38,318
Total	$159,365	$164,939	[1]
[1]	Derived from audited financial statements.

Credit_Facility_Additional_Inf

Credit Facility - Additional Information (Detail) (USD $)	3 Months Ended
	Jan. 31, 2014	Oct. 31, 2013		Feb. 17, 2012
Debt Instrument [Line Items]	'	'		'
Senior unsecured revolving credit facility entered date	17-Feb-12	'		'
Senior unsecured revolving credit facility maximum borrowing capacity	'	'		$350,000,000
Senior unsecured term loan facility, face amount	'	'		150,000,000
Senior unsecured term loan facility additional borrowings	150,000,000	'		'
Payment schedule for term loan	'Principal payments on a portion of the Term Loan are due in equal quarterly installments of $7.5 million, with the remainder due when the Credit Agreement expires in October 2016.	'		'
Debt instrument periodic payment principal	7,500,000	'		'
Senior unsecured term loan facility	97,500,000	105,000,000		'
Senior unsecured term loan facility long term	$67,500,000	$75,000,000	[1]	'
Minimum	'	'		'
Debt Instrument [Line Items]	'	'		'
Commitment fees percentage	0.15%	'		'
Maximum	'	'		'
Debt Instrument [Line Items]	'	'		'
Commitment fees percentage	0.30%	'		'
Revolver	'	'		'
Debt Instrument [Line Items]	'	'		'
Borrowings, interest rate	0.98%	'		'
Term Loan	'	'		'
Debt Instrument [Line Items]	'	'		'
Borrowings, interest rate	1.13%	'		'
[1]	Derived from audited financial statements.

Components_of_Accumulated_Othe

Components of Accumulated Other Comprehensive Income (Loss) (Detail) (USD $)	Jan. 31, 2014	Oct. 31, 2013
In Thousands, unless otherwise specified
Accumulated other comprehensive income (loss), net of tax	'	'
Cumulative currency translation adjustments	($40,696)	($26,848)
Unrealized gain (loss) on derivative instruments, net of taxes	-5,729	-1,847
Total accumulated other comprehensive income (loss)	($46,425)	($28,695)	[1]
[1]	Derived from audited financial statements.

Effect_of_Amounts_Reclassified

Effect of Amounts Reclassified out of Each Component of Accumulated Other Comprehensive Income (Loss) into Net Income (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'
Gain (loss) on cash flow hedges, net of taxes	$3,306	($279)
Foreign Exchange Contracts | Revenue	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'
Gain (loss) on cash flow hedges, net of taxes	2,756	487
Foreign Exchange Contracts | Operating Expenses	'	'
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]	'	'
Gain (loss) on cash flow hedges, net of taxes	$550	($766)

Stock_Repurchase_Program_Addit

Stock Repurchase Program - Additional Information (Detail) (USD $)	1 Months Ended	3 Months Ended
In Millions, unless otherwise specified	Dec. 03, 2013	Jan. 31, 2014	Jan. 31, 2013
Stock Repurchase Program [Line Items]	'	'	'
Stock repurchase program authorized amount	$500	$500	'
Remaining amount available for further repurchases	'	$445.30	'
Treasury stock reissued	'	1.3	1.1

Stock_Compensation_Expense_Det

Stock Compensation Expense (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock compensation expense before taxes	$18,118	$17,700
Income tax benefit	-4,220	-3,959
Stock compensation expense after taxes	13,898	13,741
Cost Of License	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock compensation expense before taxes	1,861	1,817
Cost Of Maintenance And Service	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock compensation expense before taxes	428	479
Research And Development Expense	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock compensation expense before taxes	8,916	8,136
Sales And Marketing Expense	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock compensation expense before taxes	3,732	3,673
General And Administrative Expense	'	'
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]	'	'
Stock compensation expense before taxes	$3,181	$3,595

Stock_Compensation_Additional_

Stock Compensation - Additional Information (Detail) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Jan. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]	'
Unamortized share-based compensation expense	$119.40
Weighted-average period of total compensation costs to be recognized in years	'2 years 6 months

Schedule_of_Intrinsic_Value_of

Schedule of Intrinsic Value of Equity Awards Exercised (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013
Stock Compensation [Abstract]	'	'
Intrinsic value of awards exercised	$16,199	$7,705

Reconciliation_of_Weighted_Ave

Reconciliation of Weighted Average Common Shares Used to Calculate Basic Net Income Per Share (Detail) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Jan. 31, 2014		Jan. 31, 2013
Net Income Loss Per Common Share [Line Items]	'		'
Net income	$67,696		$69,922
Weighted-average common shares for basic net income per share	154,066		151,477
Dilutive effect of potential common shares from equity-based compensation	2,690		3,054
Weighted-average common shares for diluted net income per share	156,756		154,531
Basic	$0.44		$0.46
Diluted	$0.43		$0.45
Anti-dilutive employee stock-based awards excluded	1,378	[1]	2,573	[1]
[1]	These stock options and unvested restricted stock units and restricted stock awards were anti-dilutive for the respective periods and are excluded in calculating diluted net income per share. While such awards were antidilutive for the respective periods, they could be dilutive in the future.

Segment_Disclosure_Additional_

Segment Disclosure - Additional information (Detail)	3 Months Ended
	Jan. 31, 2014	Jan. 31, 2013
	Segment	Customer
	Customer	Segment
Segment Reporting Information [Line Items]	'	'
Number of reportable operating segment	1	1
Number of major customers	1	1
Revenue	'	'
Segment Reporting Information [Line Items]	'	'
Percentage of revenues contributed by major customers	11.60%	11.00%

Revenues_Related_to_Operations

Revenues Related to Operations by Geographic Areas (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Consolidated	$478,951	$475,137
United States	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Consolidated	233,627	233,133
Europe	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Consolidated	66,654	63,439
Japan	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Consolidated	64,320	69,648
Asia-Pacific And Other	'	'
Revenues from External Customers and Long-Lived Assets [Line Items]	'	'
Consolidated	$114,350	$108,917

Components_of_Other_Income_exp

Components of Other Income (expense), Net (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014		Jan. 31, 2013
Other Income Net [Line Items]	'		'
Interest income	$367		$335
Interest expense	-357		-464
Gain (loss) on assets related to executive deferred compensation plan	1,042		5,413
Foreign currency exchange gain (loss)	893		4,404
Other, net	9,083	[1]	1,061	[1]
Total	$11,028		$10,749
[1]	Refer to Note 4. Fair Value Measures.

Provision_for_Income_Taxes_and

Provision for Income Taxes and Effective Tax Rates (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Jan. 31, 2014	Jan. 31, 2013
Taxes	'	'
Income before income taxes	$71,184	$71,730
Provision for income tax	$3,488	$1,808
Effective tax rate	4.90%	2.50%

Taxes_Additional_Information_D

Taxes - Additional Information (Detail) (USD $)	3 Months Ended
In Millions, unless otherwise specified	Jan. 31, 2014
Taxes [Line Items]	'
Statutory federal income tax rate	35.00%
Gross unrecognized tax benefits	$115
Unrecognized tax benefits that would affect effective tax rate	115
Estimated potential decrease in underlying unrecognized tax benefits, minimum	0
Estimated potential decrease in underlying unrecognized tax benefits, maximum	36
Unrecognized tax benefits decrease resulting from settlement with IRS	$10

Subsequent_Events_Additional_I

Subsequent Events - Additional Information (Detail) (Subsequent Event, Coverity Inc, USD $)	1 Months Ended
In Millions, unless otherwise specified	Feb. 19, 2014
Subsequent Event | Coverity Inc	'
Subsequent Event [Line Items]	'
Purchase consideration	$375